Stockscreener 앱 받기
32.01
0.28%
-0.09
시간 외 거래:
32.01
Enovis Corp 주식(ENOV)의 최신 뉴스
Enovis Announces Third Quarter 2024 Results - ADVFN
Enovis’s Strategic Initiatives and Acquisitions Drive Buy Rating - TipRanks
Enovis names McDonald as CEO - MSN
Enovis appoints Damien McDonald as CEO - MedTech Dive
Enovis Appoints Damien McDonald CEO, Reaffirms Q1 Guidance Amid Strategic Growth Push - insights.citeline.com
Canaccord maintains Buy rating and $75 target for Enovis stock - Investing.com Australia
Enovis Receives Buy Rating Amidst Strategic Leadership Change and Strong Financial Projections - TipRanks
Canaccord maintains Buy rating and $75 target for Enovis stock By Investing.com - Investing.com India
Enovis’s Promising Future: Buy Rating Backed by Strategic Leadership and Positive Financial Outlook - TipRanks
Enovis names Damien McDonald as new CEO starting May 12 By Investing.com - Investing.com Canada
Enovis (ENOV) Appoints New CEO and Confirms Revenue Forecast - GuruFocus
Enovis Names Damien McDonald as New CEO to Drive Next Growth Chapter - MSN
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Enovis (ENOV) and Auckland International Airport Limited (OtherACKDF) - The Globe and Mail
Enovis names Damien McDonald as CEO, succeeding Matt Trerotola - TipRanks
Strategic Leadership and Financial Stability Drive Buy Rating for Enovis - TipRanks
Enovis Appoints Damien McDonald as New CEO - TipRanks
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - Ortho Spine News
Enovis Corporation Reiterats Earnings Guidance for the First Quarter of 2025 - MarketScreener
Former LivaNova CEO to take corner office at Enovis - MassDevice
Enovis names Damien McDonald as new CEO starting May 12 - Investing.com Australia
Enovis Names Damien McDonald as Chief Executive; Reaffirms Q1 Revenue Guidance - MarketScreener
Enovis Appoints Damien McDonald as Chief Executive Officer - citybiz
Enovis Announces Appointment Of Damien Mcdonald As Chief Executive Officer - MarketScreener
Medical Device Expert Takes Helm at Enovis: Former LivaNova CEO to Drive Growth - Stock Titan
Enovis Corporation (NYSE:ENOV) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down - The Globe and Mail
Enovis Showcases Innovative Foot and Ankle Solutions at ACFAS Conference - MSN
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewswire
Enovis, Foundation Surgical and J&J MedTech Named Winners of OMTEC® Awards, Honoring Excellence in Orthopedic Innovation - Ortho Spine News
Revolutionary Bunion Surgery System Leads Enovis's Major Product Launch at ACFAS 2025 - Stock Titan
Enovis : trade; Publishes 2024 Corporate Social Responsibility Report - MarketScreener
Enovis Corp (ENOV) Stock Price Up 1.77% on Mar 19 - GuruFocus.com
Enovis Plans Leadership Change - The Healthcare Technology Report.
Enovis CEO Matthew Trerotola Announces Retirement Plan - TipRanks
Positive Outlook for Enovis: Strong Market Position and Strategic Growth Initiatives - TipRanks
Diabetic Footwear Market Demand : Identifying Key Growth Opportunities By 2032 | Enovis companies, Pilgrim - EIN News
Enovis Corporation Announces Participation in Upcoming Investor Conferences - MSN
Enovis Positioned for Growth: Buy Rating Highlights Strategic Execution and Undervaluation - TipRanks
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
Enovis Leadership Reveals Investor Conference Schedule: Key Dates for Healthcare Investors - StockTitan
Enovis Hits Another 52-Week Low. Here’s Why It’s A Contrarian Buy. - Barchart
Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy. - TradingView
Enovis : rsquo; Louie Vogt on driving recon growth past $1B with M&A, knee breakthroughs, and foot and ankle expansion - Marketscreener.com
Enovis Corporation Reports Strong Growth Amid Challenges - MSN
0.09%
1.72%
자본화:
|
볼륨(24시간):